PILOT
831175
Beijing Highlander Digital Technology
300065
Xiamen Hongxin Electronics Technology Group Inc.
300657
4
Glory View Technology
301396
5
Guangzhou LBP Medicine Science & Technology
688393
US Stock MarketDetailed Quotes
ITRM Iterum Therapeutics
- 1.5400
- +0.0400+2.67%
Close Feb 14 16:00 ET
- 1.5900
- +0.0500+3.25%
Post 19:51 ET
53.26MMarket Cap-1.22P/E (TTM)
1.5800High1.4700Low373.03KVolume1.4900Open1.5000Pre Close563.26KTurnover1.10%Turnover RatioLossP/E (Static)34.58MShares3.020052wk High-13.05P/B52.11MFloat Cap0.808052wk Low--Dividend TTM33.84MShs Float195.0000Historical High--Div YieldTTM7.33%Amplitude0.6010Historical Low1.5090Avg Price1Lot Size
Iterum Therapeutics Key Stats
EPS
According to the latest financial report of Iterum Therapeutics, the latest earnings per share (TTM) for the company is -0.21. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Iterum Therapeutics's free cash flow? The latest report shows it as -4.26M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Iterum Therapeutics shows that the company's current ratio is 1.41, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Iterum Therapeutics, the quick ratio is 1.37, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Iterum Therapeutics? The latest ROE figure is -73.42%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Iterum Therapeutics, the total asset return on investment (ROA) is -21.75%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Iterum Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Iterum Therapeutics, the net profit margin is -55.62K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025